3D model (JSmol)
|Molar mass||669.908 g·mol−1|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Caldoramide is a pentapeptide isolated from the cyanobacteria Caldora penicillata. It has cytotoxic effects on cancer cells and has been the subject of extensive oncological research. It is structurally analogous to belamide A and dolastatin 15. Its appearance is that of a powdery, white, substance.
The N-terminus for Caldoramide is N,N-dimethylvaline which is attached to a valine which is attached to an N-Me-valine connected to an N-Me-isoleucine which is attached to the C-terminus. The molecule can also be written as N,N-diMe-Val-Val-N-Me-Val-N-Me-Ile-3-O-Me-4-benzylpyrrolinone.
Freeze-dried samples of Caldora penicillata had EtOAc−MeOH and H2O−EtOH applied to them in order to extract Caldoramide. The extracts were partitioned with n-BuOH and H2O and then fractions were taken based on solubility in either EtOAc or BuOH. Caldoramide was extracted from the BuOH soluble fraction.
- Wunder A, Rothemund M, Schobert R (2018). "Synthesis and anticancer activity of the proposed structure of caldoramide, an N-peptidyltetramate from the cyanobacterium Caldora penicillata". Tetrahedron. 74 (38): 5138–5142. doi:10.1016/j.tet.2018.04.004. S2CID 103025376.
- Iwasaki A, Tadenuma T, Sumimoto S, Shiota I, Matsubara T, Saito-Nakano Y, et al. (November 2018). "Hoshinoamides A and B, Acyclic Lipopeptides from the Marine Cyanobacterium Caldora penicillata". Journal of Natural Products. 81 (11): 2545–2552. doi:10.1021/acs.jnatprod.8b00643. PMID 30387355. S2CID 53725718.
- Gunasekera SP, Imperial L, Garst C, Ratnayake R, Dang LH, Paul VJ, Luesch H (July 2016). "Caldoramide, a Modified Pentapeptide from the Marine Cyanobacterium Caldora penicillata". Journal of Natural Products. 79 (7): 1867–71. doi:10.1021/acs.jnatprod.6b00203. PMC 5215049. PMID 27380142.